2010
DOI: 10.1186/1476-4598-9-311
|View full text |Cite
|
Sign up to set email alerts
|

The antagonism between MCT-1 and p53 affects the tumorigenic outcomes

Abstract: BackgroundMCT-1 oncoprotein accelerates p53 protein degradation via a proteosome pathway. Synergistic promotion of the xenograft tumorigenicity has been demonstrated in circumstance of p53 loss alongside MCT-1 overexpression. However, the molecular regulation between MCT-1 and p53 in tumor development remains ambiguous. We speculate that MCT-1 may counteract p53 through the diverse mechanisms that determine the tumorigenic outcomes.ResultsMCT-1 has now identified as a novel target gene of p53 transcriptional r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(27 citation statements)
references
References 60 publications
(71 reference statements)
1
23
0
Order By: Relevance
“…Based on pro鈥恑nflammatory effects of macrophages and on cancer growth exerted by MIF which suppresses the function of p53 [Bifulco et al, ], one could reason that the MIF鈥恉riven cancer cell proliferation, invasiveness, and metastasis in response to IR observed in our study were due to suppressed p53 activity. However, A549 cells contain wild鈥恡ype p53 while NCI鈥怘358 cells lack expression of p53 [Kasiappan et al, ; Osborne et al, ]. Similar results from the two cell lines in almost all of our experiments suggest that p53 was not associated with the results of the present study.…”
Section: Discussionsupporting
confidence: 79%
“…Based on pro鈥恑nflammatory effects of macrophages and on cancer growth exerted by MIF which suppresses the function of p53 [Bifulco et al, ], one could reason that the MIF鈥恉riven cancer cell proliferation, invasiveness, and metastasis in response to IR observed in our study were due to suppressed p53 activity. However, A549 cells contain wild鈥恡ype p53 while NCI鈥怘358 cells lack expression of p53 [Kasiappan et al, ; Osborne et al, ]. Similar results from the two cell lines in almost all of our experiments suggest that p53 was not associated with the results of the present study.…”
Section: Discussionsupporting
confidence: 79%
“…Tumor samples were processed for immunohistochemical (IHC) staining as described previously [60]. Abs against VEGF Receptor 2 (1:800, D5B1, Cell signaling) and CD163 (1:100, ab182422, Abcam) were diluted in PBS as indicated.…”
Section: Tumor Growth In Xenograft Mice and A Tumor Immunohistochemismentioning
confidence: 99%
“…[37][38][39][40] In supporting MCT-1's tumorigenic role, overexpression of MCT-1 transforms normal breast epithelial cells and downregulates p53 expression at both gene and protein levels. 35,37,41 Moreover, MCT-1 oncogene promotes chromosome abnormalities in the p53-compromised cells upon genotoxic damage and enhances the xenograft tumorigenicity of H1299 (p53-null) lung cancer cells. 35 Though MCT-1 is phosphorylated by CDC2 and ERK kinase in vitro, 42 it is unknown whether MCT-1 is implicated in mitotic function.…”
Section: The Involvement Of Mct-1 Oncoprotein In Inducing Mitotic Catmentioning
confidence: 99%